MedPath

Effectiveness of the Lidcomb Program on Stuttering

Phase 2
Conditions
stuttering.
Childhood onset fluency disorder
F80.81
Registration Number
IRCT20200105046018N2
Lead Sponsor
Birjand University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
15
Inclusion Criteria

Stuttering
school age
No history of receiving Ledcomb treatment

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Stuttering changes due to the implementation of the Lidcomb program. Timepoint: Before the intervention, the end of the first phase and the end of the second phase of the Lidcomb program. Method of measurement: Measure the percentage of stuttered syllables.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath